NFKB1 and glioblastoma: Additionally, PBI-05204 was able to reduce NF-κB expression, commonly associated with elevated inflammation and molecules associated with resistance to radiotherapy, chemotherapy, and relative stemness of GBM (Gray et al., 2014; Soubannier and Stifani, 2017; Kaltschmidt et al., 2019).